Search
Filters
Clear All
  • 19
  • 57
  • 2
  • 601

Phase

  • 1
  • 15
  • 16
  • 47
  • 6
  • 74
  • 5
  • 505
  • 619
  • 278

Found 679 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Phase 1/2 Multi-Center Trial of Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

A
April Rahrig, MD
3 years - 39 years
All genders
Phase 1/2
Interventional
What is the purpose of this study?The purpose of this study is to determine the recommended phase 2 dose of the drug Vorinostat in children, adolescents and young adults following allogeneic blood or marrow transplant (BMT) and determine whether the addition of Vorinostat to the standard graft versus host disease …
Learn More
Older Adults Needed for IU Bloomington Beef Intake and Muscle Fatigue Study!

Older Adults Needed for IU Bloomington Beef Intake and Muscle Fatigue Study!

C
Cydne Perry
60 years - 85 years
Accepts healthy volunteer
All genders
Are you 60-85 years of age, in overall good health, and live in the Bloomington, IN area?    Researchers at the IU School of Public Health are looking for older adults to take part in a study looking at how a beef-based diet vs. a vegetarian diet affects muscle fatigue.   All study foods …
Check Eligibility
HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

J
James Chmiel
M
Mike Davis
18 years - 60 years
Accepts healthy volunteer
All genders
Researchers at Indiana University School of Medicine are researching a nasal treatment for COVID-19. We are looking for people with a recent onset of mild COVID-19 symptoms and a positive COVID-19 test in the last few days to come for a 2 hour visit at Riley Hospital for Children to help …
Check Eligibility
VOLUNTEERS AGES 21-26 NEEDED FOR ALCOHOL AND BRAIN IMAGING STUDY!

VOLUNTEERS AGES 21-26 NEEDED FOR ALCOHOL AND BRAIN IMAGING STUDY!

D
David Kareken, PhD
21 years - 27 years
Accepts healthy volunteer
All genders
Do you drink alcohol? If yes, we want to learn about your brain activity! Researchers at the IU School of Medicine are looking for volunteers aged 21-27 to participate in an alcohol and brain imaging study.Interested potential participants must complete one 3 hour in-person screening. Following the in-person screening, qualified participants in …
Learn More

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

A
Anita Turk, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are …
Learn More

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 3
Interventional
What is the purpose of this study?This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, …
Learn More

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

B
Bryan Schneider, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?This Phase III, randomized, open-label, multicenter study will evaluate the efficacy andy of giredestrant plus everolimus compared with the physician's choice of endocrineherapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer …
Learn More

Neoadjuvant pembrolizumab in patients with muscle-invasive bladder cancer with selective bladder sparing

J
Jennifer King
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?Subjects with cT2-T3N0M0 urothelial cancer of the bladder will be enrolled. After completingwo cycles of pembrolizumab, subjects will undergo a restaging MRI of the abdomen and pelvis with a standard acquisition protocol (as outlined in the protocol) as well as CT chest. A CThe …
Learn More

Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)

B
Bryan Schneider, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease afterve therapy will be assigned to 1 of 3 Arms based on plasma ctDNA positivity and genomic marker(s).THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, …
Learn More

PSMA-PET to Guide Prostatectomy

C
Clinton Bahler, MD
40 years - 80 years
Male
Phase 2/3
Interventional
What is the purpose of this study?This study will randomize subjects to either standard of care MRI prior to radical prostatectomy or standard of care MRI and the PSMA (prostate specific membrane antigen) PET scan prior to radical prostatectomy to see if this scan will be helpful in detecting prostate …
Learn More
21 - 30 of 679